Bellerophon Therapeutics (BLPH) Prices 3.077M Share Common Offering at $13/Sh; Announces Pricing of 1.15M Registered Direct Offering

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. META
6. TSLA
7. RTX
8. SMCI
9. GOOGL
10. S

Go back to Bellerophon Therapeutics (BLPH) Prices 3.077M Share Common Offering at $13/Sh; Announces Pricing of 1.15M Registered Direct Offering

After-Hours Stock Movers 05/18: (ABUS) (DAC) (BIDU) Higher; (BLPH) (GMDA) (GOSS) Lower (more...)

May 18, 2020 5:44 PM EDT

After-Hours Stock Movers:

Arbutus Biopharma Corporation (Nasdaq: ABUS) 55% HIGHER; reports positive follow-up data from a Phase 1a/1b clinical trial (AB-729-001) in chronic HBV subjects on nucleos(t)ide therapy who received a single subcutaneous injection of 60 mg of AB-729, a proprietary GalNAc delivered RNAi compound.

Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) 14.7% LOWER; announced that it intends to offer and sell shares of its common stock in an underwritten registered public offering.

Gamida Cell... More

Bellerophon Therapeutics (BLPH) to Offer Common Stock

May 18, 2020 4:03 PM EDT

Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) announced that it intends to offer and sell shares of its common stock in an underwritten registered public offering. All of the shares in the offering are to be sold by Bellerophon. Bellerophon also intends to grant the... More